Ramius Sends Letter to Newly Appointed Lead Independent Director of Cypress
NEW YORK, Aug. 25 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it delivered a letter to Daniel H. Petree, the newly appointed lead independent director of Cypress Bioscience, Inc.
FTI Consulting, Inc./Corporate Board Member Survey Shows Directors are Feeling Regulatory Heat
NEW YORK, Aug. 16 /PRNewswire-FirstCall/ -- The 10th annual legal study by Corporate Board Member and FTI Consulting, Inc. (NYSE: FCN) shows executive compensation and governance and compliance among the most pressing concerns for directors and general counsel.
The survey reports that directors' top three concerns are executive compensation (41%), governance and compliance (38%), and mergers and acquisitions ("M&A") (34%).
Concerned Osteotech Stockholders Announce Nomination of Four New Members to the Board of Directors of Osteotech, Inc.
NEW YORK, Aug. 4 /PRNewswire/ -- Spencer Capital Opportunity Fund, L.P., Boston Avenue Capital LLC and Heartland Advisors, Inc. (the "Concerned Osteotech Stockholders") filed a definitive proxy statement today nominating four highly qualified healthcare and corporate finance executives to the board of Osteotech, Inc.
